Apeiron Synthesis is a technology company specializing in tailor-made catalyst synthesis and fine-tuning for the pharmaceutical, polymer, and renewables industries. They have developed an innovative olefin metathesis technology platform to provide robust and scalable solutions for sustainable and cost-efficient production of new and existing chemical products. Apeiron's catalysts are compatible with aqueous media and enable polypeptide synthesis, DNA and mRNA modification, as well as the preparation of specialty polymers. They offer a wide portfolio of latent catalysts dedicated to Ring Opening Metathesis Polymetization (ROMP) reaction and provide innovative catalyst solutions tailored to specific needs. Apeiron Synthesis is at the forefront of developing solutions that address issues facing the pharmaceutical, polymer, and renewables industries.
Headquarters
Ul. Dunska 9
Wroclaw; Dolnoslaskie;
Postal Code: 54-427
Contact Details: Purchase the Apeiron Synthesis S.A. report to view the information.
Website: http://www.apeiron-synthesis.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service